Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis.
Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.
The investigation of acute optic neuritis: a review and proposed protocol.
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Phase IV Study Reports Multiple Sclerosis Success with Teriflunomide
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Animal Models in Neurology: Drawbacks and Opportunities.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
The environment and disease: association or causation?
Systematic approaches to central nervous system myelin.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Mutations affecting segment number and polarity in Drosophila.
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Tysabri
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis

Pages